NYMOX PHARMACEUTICAL CORPORATION Interest Income On Loans And Receivables
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Interest Income On Loans And Receivables of $250.00 thousand for the 0-month period ending 2024-01-15, per its 6-K filed 2025-01-02.
Financial Statements › Income Statement › Other Income
ifrs-full:InterestIncomeOnLoansAndReceivables · last filed 2025-01-02
- 2024-01-15: Interest Income On Loans And Receivables 0 month $250.00K.
- 2023-10-31: Interest Income On Loans And Receivables 1 month $250.00K.
- 2023-10-11: Interest Income On Loans And Receivables 0 month $500.00K.
| Period end | Interest Income On Loans And Receivables 0 month | Interest Income On Loans And Receivables 1 month |
|---|---|---|
| 2024-01-15 | $250.00K 6-K · filed 2025-01-02 | |
| 2023-10-31 | $250.00K 6-K · filed 2025-01-02 | |
| 2023-10-11 | $500.00K 6-K · filed 2025-01-02 |